KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 108 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,279,297 | +22.9% | 534,214 | -0.4% | 0.33% | +42.7% |
| Q2 2023 | $7,552,920 | +22.1% | 536,429 | -6.7% | 0.23% | +23.4% |
| Q1 2023 | $6,186,354 | -18.1% | 574,940 | +14.0% | 0.19% | -18.6% |
| Q4 2022 | $7,552,811 | +6.5% | 504,193 | -8.7% | 0.23% | -0.4% |
| Q3 2022 | $7,092,000 | +74.3% | 552,350 | +31.5% | 0.23% | +66.9% |
| Q2 2022 | $4,070,000 | -44.8% | 419,995 | -43.4% | 0.14% | -24.0% |
| Q1 2022 | $7,377,000 | +4.5% | 742,158 | +23.8% | 0.18% | +26.2% |
| Q4 2021 | $7,056,000 | +52.7% | 599,522 | +47.7% | 0.14% | +64.8% |
| Q3 2021 | $4,622,000 | – | 405,834 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |